Last Posted: May 17, 2020
- A comprehensive germline variant and expression analyses of ACE2, TMPRSS2 and SARS-CoV-2 activator FURIN genes from the Middle East: Combating SARS-CoV-2 with precision medicine
F Al-Mulla et al, BIORXIV, May 16, 2020 - Clinical Application of Computational Methods in Precision Oncology- A Review
OA Panagiotou et al, JAMA Oncology, May 14, 2020 - Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.
Schwartzlow Coreen et al. Current neurology and neuroscience reports 2019 19(8) 52 - Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.
Marshall Deborah A et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 May 23(5) 566-573 - Genetics of dilated cardiomyopathy: practical implications for heart failure management.
Rosenbaum Andrew N et al. Nature reviews. Cardiology 2020 17(5) 286-297 - Reactive Artificial Intelligence Using "Big Data" in the Era of Precision Medicine-Reply.
Loftus Tyler J et al. JAMA surgery 2020 May - Returning genomic results in a Federally Qualified Health Center: the intersection of precision medicine and social determinants of health.
Shaibi Gabriel Q et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 May - Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
Božina Nada et al. Croatian medical journal 2020 Apr 61(2) 147-158 - Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
Deverka Patricia A et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 May 23(5) 540-550 - Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.
Faulkner Eric et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 May 23(5) 529-539
No hay comentarios:
Publicar un comentario